Strides Pharma Science Limited (NSEI: STAR)
Health Care · Pharmaceuticals · IN
Rs1,085.30
+0.05% today · +27.6% 1Y
Strides Pharma Science Limited (NSEI: STAR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.03B and employs 3,535 people.
Over the last twelve months the share price has gained 27.6%, trading between 768.65 and 1.26K.
Tweenvest scores Strides Pharma Science Limited across four factors: quality 72/100, value 46/100, growth 54/100, dividend 46/100. Its strongest factor is quality.
STAR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.03B
- Revenue (TTM)
- $529.27M
- P/E
- 16.31
- EPS
- 66.55
- Dividend yield
- 0.46%
- Beta (5Y)
- 0.37
- 52-week high
- Rs1,260.90
- 52-week low
- Rs768.65
- Avg volume (3M)
- —
- Shares outstanding
- 92.17M
- Employees
- 3,535
- Next earnings
- —
About Strides Pharma Science Limited
Strides Pharma Science Limited is a pharmaceutical company that focuses on the development, production, and worldwide commercialization of medicinal products. Its extensive global footprint spans Africa, Australia, North America, Europe, Asia, India, and various other international markets. The company's operations are structured into two distinct segments: Pharmaceutical and Biopharmaceutical. It provides a diverse range of generic pharmaceuticals, available in multiple formats including tablets, hard and soft gelatin capsules, sachets, liquids, nasal sprays, powders, solids, ointments, and creams. Furthermore, Strides Pharma Science creates branded generic offerings for treating chronic ailments such as women's health issues, central nervous system disorders, cardiovascular conditions, diabetes, dermatological concerns, and probiotic support, marketed under brands like Renerve, Unibrol, Combiart, Duotab, and Vitafer. For institutional business, the company supplies drugs targeting infectious diseases, including anti-retrovirals, anti-malarials, anti-tuberculosis, and Hepatitis treatments. Incorporated in 1990, the company is headquartered in Bengaluru, India. It was formerly known as Strides Shasun Limited before adopting its current name in July 2018.
- ISIN
- INE939A01011
- Founded
- 1990
- Listed since
- Jun 26, 2002
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jiangsu Kanion Pharmaceutical Co.,Ltd.SHSE: 600557 | $1.05B | CN¥12.40 | +0.81% |
| Hunan Warrant Pharmaceutical Co.,LtdSHSE: 688799 | $1.05B | CN¥52.45 | -8.32% |
| Northeast Pharmaceutical Group Co., Ltd.SZSE: 000597 | $1.05B | CN¥4.91 | +3.15% |
| Hunan Er-Kang Pharmaceutical Co., LtdSZSE: 300267 | $1.03B | CN¥3.36 | +3.07% |
| China Animal Husbandry Industry Co., Ltd.SHSE: 600195 | $1.03B | CN¥6.73 | +1.36% |
| Dezhan Healthcare Company LimitedSZSE: 000813 | $1.02B | CN¥3.26 | +0.93% |
| Vetoquinol SAENXTPA: VETO | $1.01B | €75.10 | -3.22% |
| Zhejiang Ausun Pharmaceutical Co., Ltd.SHSE: 603229 | $1.01B | CN¥8.19 | -0.85% |
Figures last refreshed Oct 11, 2026.